Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 5 days ago
2	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	What to Know About Delta-8 and Other Common Vape Shop Drugs - 14 days ago More people die after smoking drugs than injecting them, study finds - 7 months ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 27 days ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - 5 months ago Is 2024 the Year for Psychedelic Medicine? - 6 months ago Key Market Trends for the Current Specialty Drug Pipeline - 11 months ago Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages - 12 months ago
4	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	Daily briefing: Deepfakes hawk fake drugs using scientists’ faces - about 1 month ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - about 1 month ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 6 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 7 months ago STAT+: Pharmalittle: We’re reading about a pharma job slowdown, diet drugs boosting GDP, and more - 7 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 7 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 9 months ago STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial - 9 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - 11 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 12 months ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - 12 months ago
6	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	A tough week for MDMA-assisted psychotherapy - about 1 month ago FDA rejects MDMA as a psychedelic treatment for PTSD - about 1 month ago Psychedelic investment continues to ramp up - 7 months ago
7	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The FDA Just Rejected a Bid for MDMA to Treat PTSD - about 1 month ago
8	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	MDMA therapy didn’t get FDA approval. Now what? - about 1 month ago
9	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Buying shady weight loss drugs online is a bad idea, in case you were wondering - about 2 months ago
10	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Neuro drugs are still faltering, despite rising investment - about 2 months ago

Journalists covering drugs